Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M
Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets
Register to read this story and more for free.
Signing up for an account helps us improve your browsing experience.
OR
See our subscription options.